| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |